Decellularized fresh homografts for pulmonary valve replacement: a decade of clinical experience
Author(s) -
Samir Sarikouch,
Alexander Horke,
I. Tudorache,
Philipp Beerbaum,
Mechthild WesthoffBleck,
Dietmar Boethig,
Repin Oleg,
Maniuc Liviu,
Anatol Ciubotaru,
Axel Haverich,
Serghei Cebotari
Publication year - 2016
Publication title -
european journal of cardio-thoracic surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.303
H-Index - 133
eISSN - 1873-734X
pISSN - 1010-7940
DOI - 10.1093/ejcts/ezw050
Subject(s) - decellularization , medicine , surgery , biomedical engineering , tissue engineering
Decellularized homografts have shown auspicious early results when used for pulmonary valve replacement (PVR) in congenital heart disease. The first clinical application in children was performed in 2002, initially using pre-seeding with endogenous progenitor cells. Since 2005, only non-seeded, fresh decellularized allografts have been implanted after spontaneous recellularization was observed by several groups.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom